ESC 2019: Commentary on the PROVE-HF and EVALUATE-HF Studies

Published: 28 Oct 2019

  • Views:

    Views Icon 454
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating


In this video Prof Scott Solomon (Harvard Medical School, MA, US) and Prof Andrew Coats (University of Warwick, UK) discuss the Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes (PROVE-HF) and Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction (EVALUATE-HF) studies and their applicability to practice.


Filmed on site at ESC 2019 by Radcliffe Cardiology.

Videography: Mike Knight & Tom Green

This interview is a component of a wider Radcliffe Education programme entitled,'Review of emerging ARNI data in HFrEF'. Certified accreditation of the full programme has been provided by the European Board for Accreditation in Cardiology (EBAC). The accredited programme is available at

This video was partially funded by an unrestricted educational grant from Novartis.